Panacea Biotec Limited — Board Meeting, 13-08-2026: Outcome of Board Meeting
13-08-2026 | 06:46 pm
13-08-2026 | 06:46 pm
Panacea Biotec's Board approved consolidated Q1 results: Total income ₹199.57 Cr, Net Profit ₹2.20 Cr (EPS ₹0.38). Exceptional income added ₹2.74 Cr. The 42nd AGM is set for Sept 29, 2026, via VC. Group financials show positive retained earnings, even with a standalone 'going concern' note.
No comments yet. Be the first to comment!
